title: Physiological assessment of muscle strength in vitro after direct injection of doxorubicin into rabbit sternocleidomastoid muscle.
abstract: Doxorubicin chemomyectomy is a potent method for the permanent removal of a muscle or group of muscles after direct local injection, and has been used successfully to treat blepharospasm and hemifacial spasm patients. The efficacy of doxorubicin chemomyectomy on reducing muscle strength after direct injection of doxorubicin into rabbit sternocleidomastoid muscle was tested. One- and 6-month postinjection force assessment was performed in vitro to measure alterations in peak twitch and tetanic force generation, as well as fatigue responses for the treated muscles compared to control. There were significant reductions of both twitch and tetanic peak amplitudes in the doxorubicin-treated muscles. One month after treatment, the decreases in force were greater after 2 mg doxorubicin injections than after 1 mg doxorubicin. While there was a significant reduction in force generation after doxorubicin treatment, fatigue resistances for the doxorubicin-treated muscles were increased compared to the controls. There were significant reductions in muscle mass after doxorubicin treatment, and by 6 months, the myosin heavy chain isoform distribution was similar to normal sternocleidomastoid, except for an increase in slow myosin-positive fibers. Doxorubicin chemomyectomy resulted in a significant reduction in functional force generation in the treated sternocleidomastoid muscles. These findings suggest a potential clinical use of doxorubicin chemomyectomy to treat cervical dystonia patients.
authors.affiliation: Department of Physiology, University of Minnesota, Minneapolis, Minnesota 55455, USA.
authors.forename: J H
authors.initials: JH
authors.lastname: Falkenberg
authors.forename: P A
authors.initials: PA
authors.lastname: Iaizzo
authors.forename: L K
authors.initials: LK
authors.lastname: McLoon
mesh_terms: D000818:Animals; D004305:Dose-Response Relationship, Drug; D004317:Doxorubicin / Q000494:pharmacology*; D066298:In Vitro Techniques; D007273:Injections, Intramuscular; D007537:Isometric Contraction / Q000187:drug effects*; D018482:Muscle, Skeletal / Q000187:drug effects*; D009334:Neck Muscles / Q000187:drug effects; D011817:Rabbits
chemical_list: D004317:Doxorubicin